Z-0529-2016 Class III Terminated
FDA device recall Z-0529-2016 was initiated by Ameditech Inc on Nov 16, 2015 and is designated Class III. Reason for recall: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the… The recall status is terminated (terminated Nov 9, 2016). Affected quantity: 200 kits.
Recall details
- Product Type
- Devices
- Report Date
- Dec 30, 2015
- Initiation Date
- Nov 16, 2015
- Termination Date
- Nov 9, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 200 kits
Product description
ProScreen 6 Panel Dip Drug Screen, Item No. PSD-6BUPO3
Reason for recall
Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
Distribution pattern
Nationwide Distribution.
Code information
152112 152705 153400
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0529-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026